Director, Early Commercial Strategy

Cookie Notice**Title:**Director, Early Commercial Strategy**Company:**Ipsen Pharma (SAS)**About Ipsen:**Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.

S., France and the U.

K, we tackle areas of high unmet medical need through research and innovation. Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society!

• Neuroscience therapeutic Area & Franchise strategy evolution Internal Pipeline Commercial Planning Commercial evaluations of new global business opportunities

At Ipsen, we are committed to advancing transformative neuromodulator therapies in Neuroscience, with a strategic focus on migraine, movement disorders, and cervical dystonia. To deliver on this ambition, we are strengthening our internal pipeline, including the continued development of IPN10200, currently progressing through Phase 2. As we evolve our Neuroscience franchise, building robust early commercial foundations for our assets is critical to shaping future therapeutic area strategy and ensuring long‐term franchise impact.

To support this, we are expanding our therapeutic neuroscience team to enhance early commercial planning and strengthen strategic decision‐making across the Neuroscience pipeline. The Director, New Product Planning & Strategy plays a central role in guiding asset strategy (mainly IPN 10200 and Dysport in therapeutic indications) from early development onward, informing indication prioritization, shaping lifecycle planning, and partnering closely with cross‐functional teams to ensure that commercial insights are embedded early and effectively.

This is a global role with responsibility for shaping the commercial strategy across all early-stage Neuroscience assets as well as Dysport within the Tx franchise.

This position directly influences Ipsen’s future Neuroscience portfolio and contributes to delivering on our long‐term vision as a focused, innovation‐driven biopharmaceutical company.**MAIN RESPONSIBILITIES & TECHNICAL COMPETENCIES****Internal Pipeline: Early Commercial Planning**

• Lead early commercial planning process for IPN10200, including indication prioritization, portfolio strategy, lifecycle management planning, and business case development.
• Facilitate analyses required to support commercialization and/or continued development of new products.
• Support cross-functional and country teams in pre-launch activities, playing a pivotal role in the transition of these activities to a fully dedicated Global Brand Team as the asset progresses through its lifecycle.
• Key deliverables include: brand strategy and launch plan, launch readiness review, campaign and core messaging, global launch sequence, and lifecycle indication prioritization.
• Provide commercial leadership for Dysport lifecycle strategy, including long‐term indication assessment, market evolution analysis, competitive scenario planning, and identification of future growth opportunities within the Tx franchise.
• Ensure alignment with the long‐term Neuroscience Therapeutic Area strategy, embedding commercial insights and strategic assumptions across early asset planning, Dysport strategy development, and cross‐functional asset decision‐making.
• Lead global strategic commercial inputs into forecasting and Long‐Range Planning (LRP), ensuring robust, evidence‐based assumptions that reflect epidemiology, competitive intelligence, treatment dynamics, and pricing & access considerations across all Neuroscience Tx assets, including Dysport.**Strategy & Innovation**
• Support the Neuroscience Therapeutic Area Lead (Tx) and collaborate closely with cross‐functional partners (e.g., R&D, Medical Affairs, Regulatory, Strategy & Transformation, Global Pricing & Access, Forecasting, and country teams) to lead the strategic planning process for the Neuroscience Tx franchise.
• Conduct landscape assessments, analogue and competitor benchmarking, patient journey and segmentation work, and market evolution analyses to inform the ongoing development and refinement of the Neuroscience Therapeutic Area strategy.
• Develop clear, insight‐driven strategic narratives and materials (including slides, briefs, and recommendation papers) that synthesize commercial, scientific, and market insights to support governance discussions and strategic decision‐making.
• Work with internal asset teams to ensure early commercial insights, market needs, and strategic considerations are incorporated into the evolution of each asset’s development and lifecycle planning.
• Ensure that insights from early‐stage assets and Dysport are fully integrated into the long‐term Neuroscience Tx Therapeutic Area strategy, supporting a cohesive commercial vision that guides portfolio prioritization, asset progression, and long‐range planning.**Business Development: Commercial Evaluation (as needed)**
• Serve as the commercial lead for Neuroscience Tx in business development evaluations when opportunities are brought forward by the BD team, providing strategic commercial input.
• Conduct focused commercial assessments (e.g., market sizing, competitive landscape review, treatment dynamics, and value drivers) to inform screening, triage, or due‐diligence activities for BD‐initiated opportunities.
• Synthesize commercial insights and provide clear recommendations to governance bodies and cross‐functional stakeholders to support informed decision‐making on potential external opportunities.
• Ensure evaluations remain efficient, proportionate, and aligned with internal Neuroscience strategy, recognizing that BD support represents a small component of the overall remit of this role.
• Work collaboratively with R&D and other critical functions within the Global Asset Teams to ensure efficient execution with a long-term commercial vision.# **KNOWLEDGE & EXPERIENCE****Knowledge & Experience (essential):**
• Significant experience in early commercial roles within a pharmaceutical or biopharmaceutical industry at global level, or Strategy Consulting experience in life sciences (including work in early-commercial strategy, commercialization, LCM, etc.)
• Experience in early commercial planning, launch planning and disease area strategy either as part of a pharmaceutical/ biopharma or a consultancy company
• Experience in working across a cross-functional matrix team to meet deliverables on time and budget
• Strong scientific and commercial experience with a proven knowledge of business development and launch activities
• Strong communication and presentation skills
• Demonstrated exceptional strategic thinking
• Sense of urgency and experience in delivering parallel workstreams efficiently
• Deep strategic marketing expertise (positioning, targeting, segmentation, life cycle management)
• Strong business acumen and understanding of global markets
• Excellent analytical skills and strategic thinking
• Competitive landscaping
• Conducting qualitative & quantitative market research
• Strong planning and project management skills
• Excellent business case modelling and presentation skills (Excel & Power

Point use)**Education / Certifications (essential):*** Advanced degree

#J-18808-Ljbffr